Le Lézard
Classified in: Business
Subject: LAW

LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors to Contact the Firm


SAN DIEGO, Aug. 2, 2020 /PRNewswire/ -- Johnson Fistel, LLP, announces that class action lawsuits have been commenced on behalf of shareholders of the publicly-traded companies listed below. The Private Securities Litigation Reform Act of 1995 permits any investor who purchased common stock during the Class Period to seek appointment as lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation.  The lead plaintiff can select a law firm of its choice.  An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.  If you wish to serve as lead plaintiff, you must move the Court no later than the dates listed below.

If you are a long-term shareholder of any of these companies and have held shares continuously since before the class period start date, you may have standing to hold the officers and directors liable for company losses; assisting in holding the company harmless and potentially reforming corporate governance to prevent future wrongdoing. If you want to discuss this action or have any questions concerning this notice, please contact lead analyst Jim Baker ([email protected]) at 619-814-4471. If emailing, please include a phone number.

Company Name

Stock Ticker

Join

Class Period

Start

Class Period

End

Lead Plantiff

Deadline

Enphase Energy, Inc.

(NASDAQ:ENPH)

Click Here

2/26/2019

6/17/2020

8/17/2020

Chembio Diagnostics, Inc. 

(NASDAQ:CEMI)

Click Here

4/1/2020

6/16/2020

8/17/2020

Co-Diagnostics, Inc. 

(NASDAQ:CODX)

Click Here

2/25/2020

5/15/2020

8/17/2020

Casper Sleep Inc. 

(NYSE:CSPR)

Click Here

12/31/1969

12/31/1969

8/18/2020

Endo International plc 

(NASDAQ:ENDP)

Click Here

8/8/2017

6/10/2020

8/18/2020

Energy Recovery, Inc. 

(NASDAQ:ERII)

Click Here

8/2/2017

6/29/2020

8/21/2020

PlayAGS, Inc.

(NYSE:AGS)

Click Here

8/2/2018

8/7/2019

8/24/2020

Brookdale Senior Living Inc. 

(NYSE:BKD)

Click Here

8/10/2016

4/29/2020

8/24/2020

Cheetah Mobile Inc. 

(NYSE:CMCM)

Click Here

3/25/2019

2/20/2020

8/25/2020

Ideanomics, Inc. 

(NASDAQ:IDEX)

Click Here

3/20/2020

6/25/2020

8/27/2020

About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York, and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit https://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.

Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
[email protected]

 

SOURCE Johnson Fistel, LLP


These press releases may also interest you

at 16:05
Immunome, Inc. , a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced financial results for the full year ended December 31, 2023, and provided an overview of recent developments....

at 16:05
Danimer Scientific, Inc. ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today financial results for its fourth quarter and full year, ended...

at 16:05
EACO Corporation today reported the results for its quarter ended February 29, 2024. Net sales, net income and earnings per share were as follows for the three months ended February 29, 2024 (dollars in thousands, except per share information):...

at 16:05
CVD Equipment Corporation , today announced its financial results for the fourth quarter and fiscal year ended December 31, 2023. Manny Lakios, President and CEO of CVD Equipment Corporation, commented, "Fourth quarter 2023 revenue was $4.1...

at 16:05
Leafly Holdings, Inc. ("Leafly" or "the Company") , a leading online cannabis discovery marketplace and resource for cannabis consumers, today announced financial results for its fourth quarter and year ended December 31, 2023. "We saw continued...

at 16:05
Helius Medical Technologies, Inc. ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced results for the quarter and full year ended December...



News published on and distributed by: